Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Aurora
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Aurora, IL

Studies commonly pay $75 to $4,500 per completed study

615 clinical trials are currently recruiting participants within 30 miles of Aurora. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

615studies recruiting
1+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Aurora right now

Top 25 of 615 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Loyola University Medical Center (Adults and Pediatrics) — Maywood, Illinois (24.4 mi) · Sponsor: Pierre Fabre Medicament

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Edward-Elmhurst Cancer Center /ID# 238552 — Elmhurst, Illinois (20.3 mi) · Sponsor: AbbVie

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Endometrial Cancer Phase 2, Phase 3 Interventional 268 participants sought
Dr. Sudarshan K. Sharma, Ltd. — Hinsdale, Illinois (18.4 mi) · Sponsor: Kartos Therapeutics, Inc.

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Advocate Outpatient Center - Aurora — Aurora, Illinois (1.6 mi) · Sponsor: NRG Oncology

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi) · Sponsor: SCRI Development Innovations, LLC

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
Midwest Digestive Health & Nutrition — Des Plaines, Illinois (28.0 mi) · Sponsor: Eli Lilly and Company

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Pancreatic Cancer Phase 2 Interventional 60 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (7.1 mi) · Sponsor: Proton Collaborative Group

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Rush-Copley Medical Center — Aurora, Illinois (1.6 mi) · Sponsor: SWOG Cancer Research Network

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (16.1 mi) · Sponsor: Genentech, Inc.

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Alzheimers Disease, Dementia Phase 2, Phase 3 Interventional 280 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi) · Sponsor: Washington University School of Medicine

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (7.1 mi) · Sponsor: NRG Oncology

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10025, Naperville, IL — Naperville, Illinois (7.5 mi) · Sponsor: Colorado Prevention Center

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Solid Tumours Phase 2 Interventional 588 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi) · Sponsor: Boehringer Ingelheim

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50717 — Willowbrook, Illinois (18.3 mi) · Sponsor: UCB Biopharma SRL

Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor

Perinatal Decision Making N/A Interventional 2,200 participants sought
Rush Copley Medical Center — Aurora, Illinois (1.6 mi) · Sponsor: Endeavor Health

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Orland Park, Illinois (24.3 mi) · Sponsor: Ambros Therapeutics, Inc.

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Chronic Idiopathic Constipation (CIC) Phase 3 Interventional 692 participants sought
Southwest Gastroenterology — Oak Lawn, Illinois (27.7 mi) · Sponsor: Ardelyx

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Prostate Cancer N/A Interventional 70 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (7.1 mi) · Sponsor: Proton Collaborative Group

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction Phase 3 Interventional 2,000 participants sought
Fox Valley Clinical Research Center, LLC — Aurora, Illinois (1.6 mi) · Sponsor: Uppsala University

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 2 Interventional 99 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (7.1 mi) · Sponsor: Genentech, Inc.

SELUTION4BTK Trial

Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities N/A Interventional 376 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi) · Sponsor: M.A. Med Alliance S.A.

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma Phase 1, Phase 2 Interventional 97 participants sought
University of Chicago Medicine-Orland Park — Orland Park, Illinois (24.3 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Psychosis Associated With Alzheimer's Disease Phase 3 Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (18.9 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Actively enrolling

Studies you may be able to join near Aurora

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Aurora

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Fox Valley Clinical Research Center

1320 N Highland Ave Ste A, Aurora, IL 60506
(630) 723-3487

Clinical trials in Aurora: what's recruiting

The Aurora area currently has 615 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Aurora, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular3 studies
  • Immune & Skin2 studies
  • Brain & Mental Health2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Aurora, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Aurora

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Aurora participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Aurora pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Aurora?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Aurora safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Aurora?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Aurora typically complete one or two studies per year.

Paid clinical trials near Aurora

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IL

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts